http://www.legislation.gov.uk/eur/2014/1062/chapter/3Commission Delegated Regulation (EU) No 1062/2014 of 4 August 2014 on the work programme for the systematic examination of all existing active substances contained in biocidal products referred to in Regulation (EU) No 528/2012 of the European Parliament and of the Council (Text with EEA relevance)Commission Delegated Regulation (EU) No 1062/2014Commission Delegated Regulation (EU) No 1062/2014 of 4 August 2014 on the work programme for the systematic examination of all existing active substances contained in biocidal products referred to in Regulation (EU) No 528/2012 of the European Parliament and of the Council (Text with EEA relevance)King's Printer of Acts of Parliamenthttps://webarchive.nationalarchives.gov.uk/eu-exit/https://eur-lex.europa.eu/legal-content/EN/TXT/?uri=CELEX:02014R1062-20190330texttext/xmlen2025-04-23Expert Participation2025-02-27 CHAPTER 3 <Strong>CHANGES OF ELEMENTS OF THE REVIEW PROGRAMME</Strong> Joining or replacing participants by mutual agreementArticle 101The role of participant may be taken over or shared by mutual agreement between an existing participant and a prospective participant, provided that the prospective participant has the right to refer to all the data submitted or referred to by the existing participant.2A notification for the purpose of this Article shall be submitted jointly to the competent authority by the prospective and the existing participant through the system for the exchange of information between the competent authority and applicants referred to in Article 71 of Regulation (EU) No 528/2012 ..., and shall include all relevant letters of access.3Upon receipt of a notification complying with paragraph 2, the competent authority shall update its records with respect to the identity of the participant.4A person established in the United Kingdom having taken over or joined the role of participant pursuant to this Article shall be considered as having submitted a dossier or a letter of access to a dossier for the purpose of Article 95 of Regulation (EU) No 528/2012. Participants' withdrawalArticle 111A participant shall be considered to have withdrawn its support for a substance/product-type combination in the review programme in the following cases:awhere it has informed the ... competent authority ... of its intention to withdraw;bwhere it has failed to submit an application within the time limits specified in Article 3(2);cwhere its application has been rejected pursuant to ..., Article 4(4) or Article 5(4);dwhere it has failed to provide the additional information within the time limits provided for by Article 6(5);ewhere it has otherwise failed to pay the fees payable to the competent authority.2A withdrawal shall be considered as timely unless it occurs after the date when the ... competent authority submits its competent authority report to the applicant pursuant to Article 6(4) of this Regulation. Consequences of a timely withdrawalArticle 121. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .2Where a timely withdrawal is known to the competent authority, it shall update its records with respect to the identity of the participant.3Where all participants supporting the same substance/product-type combination have made a timely withdrawal from the review programme, and where the role of participant for that combination has previously been taken over, the competent authority shall inform the Secretary of State and the Devolved Authorities ... Redefinition of active substancesArticle 131Where the evaluation of an existing active substance does not allow for conclusions to be drawn relating to the substance as identified in Annex II, the ... competent authority shall, after consultation with the participant concerned, establish a new substance identity. ...2The competent authority shall update its records with respect to the identity of the substance. Taking over the role of participantArticle 141The competent authority shall publish an open invitation to take over the role of participant for a substance/product-type combination where one of the following cases applies:awhere all participants supporting the same substance/product-type combination have made a timely withdrawal pursuant to Article 11, and the role of participant for that combination has not previously been taken over;bfollowing a redefinition pursuant to Article 13, in which case, the invitation shall only concern any substance covered by the existing identity in Annex II, but not by the new substance identity.2Within 12 months from the date of the publication referred to in paragraph 1, any person may submit a notification for the combination pursuant to Article 17.3. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Substance/product-type combinations eligible for inclusion in the review programmeArticle 15Where a biocidal product covered by the scope of Regulation (EU) No 528/2012 and being placed on the market consists of, contains or generates an existing active substance which is neither approved, nor included in the review programme, for the product-type, and is not included in the Simplified Active Substance List, that substance shall be eligible for inclusion in the review programme for the relevant product-type on any of the following grounds:the product was placed on the market before IP completion day and the person placing the product on the market has relied on guidance published by, or written advice received from, the Commission or a competent authority designated in accordance with Article 26 of Directive 98/8/EC or Article 81 of Regulation (EU) No 528/2012, where that guidance or advice gave objectively justified reasons to believe that the product was excluded from the scope of Directive 98/8/EC or of Regulation (EU) No 528/2012, or that the relevant product-type was one for which the active substance had been notified and where that guidance or advice is subsequently reviewed in a decision adopted pursuant to Article 3(3) of Regulation (EU) No 528/2012 or in new, authoritative guidance published by the Commission before IP completion day or the competent authority after IP completion day;the product was placed on the market after IP completion day and the person placing the product on the market has relied on guidance published by, or written advice received from, the competent authority after IP completion day, where that guidance or advice gave objectively justified reasons to believe that the product was excluded from the scope of Regulation (EU) No 528/2012, or that the relevant product-type was one for which the active substance had been notified and where that guidance or advice is subsequently reviewed in a decision issued pursuant to Article 3(3) of Regulation (EU) No 528/2012 or in new, authoritative guidance published by the Competent Authority;the substance has benefitted from the derogation for food and feed provided for by Article 6 of Regulation (EC) No 1451/2007 and the person placing the product on the market has complied with the time limits provided for by Regulation (EU) No 528/2012;... Declaration of interest to notifyArticle 161A declaration of interest to notify a substance which is eligible for inclusion in the review programme pursuant to Article 15 shall be submitted through the system for the exchange of information between the competent authority and applicants referred to in Article 71 of Regulation (EU) No 528/2012 by any person with an interest to notify a substance/product-type combination to the competent authority at the latest 12 months after the publication of the decision or guidance referred to in point (a) or (aa) of Article 15.2A declaration shall indicate the relevant substance/product-type combination. In cases referred to in point (a) or (aa) of Article 15, the declaration shall provide a substantiated justification showing that all the conditions listed therein are fulfilled.3Where a declaration has been made in a case referred to in point (a) or (aa) of Article 15, and the competent authority finds, that paragraph 6 is not applicable, and, where relevant, that the conditions for notification listed in point (a) or (aa) of Article 15 are fulfilled, it shall update its records accordingly.4Where the competent authority determines that a declaration made under paragraph 3 is valid, the competent authority shall make that information publicly available by electronic means, mentioning the relevant substance/product-type combination. For the purposes of this Regulation, a publication made pursuant to the third subparagraph of Article 3a(3) of Regulation (EC) No 1451/2007 shall be considered as a publication made pursuant to this paragraph.5Within 6 months from the date of a publication referred to in paragraph 4, any person with an interest to notify the substance/product-type combination may do so pursuant to Article 17.6In cases referred to in points (a) and (aa) of Article 15, a substance/product-type combination shall be considered as notified by a participant, and shall not be eligible for additional notification where the following conditions apply:athe relevant active substance is already included in the review programme;bone of the dossiers submitted to the competent authority for the relevant active substance already contains all the data required for the evaluation of the product-type;cthe participant which has submitted that dossier indicates an interest to support the substance/product-type combination. Notification procedureArticle 171Notifications pursuant to Article 14(2) or Article 16(5) shall be made to the competent authority.2The notification shall be submitted in accordance with the format specified under Article 79 of Regulation 528/2012. It shall contain the information referred to in Annex I.3. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .4Upon receipt of a notification, the competent authority shall inform the notifier of the fee payable. If the notifier fails to pay the appropriate fee within 30 days from the receipt of that information, the competent authority shall reject the notification and inform the notifier.5Upon receipt of payment of the fees, the competent authority shall verify within 30 days whether the notification complies with the requirements of paragraph 2. If the notification does not comply with those requirements, the competent authority shall grant the notifier a period of 30 days in which to complete or correct the notification. After the expiry of that 30-day period, the competent authority shall, within 30 days, either declare that the notification complies with the requirements of paragraph 2 or reject the notification...6An appeal may be brought, in accordance with Article 77 of Regulation (EU) No 528/2012 against decisions of the competent authority taken pursuant to ... paragraph 5.7Where a notification has been found compliant pursuant to paragraph 5, the competent authority shall without delay:awhere the notification has been submitted pursuant to Article 14(2), update its records with respect to the identity of the participant and, where relevant, of the substance;bwhere the notification has been submitted pursuant to Article 16(5), update its records. Inclusion in the review programmeArticle 18Where a substance/product-type combination is considered notified in accordance with Article 16(6) or 17(7)(b) the Secretary of State shall include the substance/product-type combination in the review programme.The paragraph above is subject to the consent requirement. Information on substances no longer supported under the review programmeArticle 19Where no notification has been received within the time limit referred to in Article 16(5), or where a notification referred to in that Article has been received and subsequently rejected by the competent authority pursuant to Article 17(4) or (5), the competent authority shall ... publish that information electronically. <CommentaryRef Ref="key-570ba128d1d577ae6b32eb1a44db3834"/>... Decisions on substances no longer supported under the review programmeArticle 20The competent authority shall make a recommendation to the Secretary of State to issue a non-approval decision pursuant to ... Article 89(5) of Regulation (EU) No 528/2012 in the following cases:where the competent authority informs the Secretary of State and the Devolved Authorities of all participants' timely withdrawal pursuant to Article 12(3) of this Regulation;where no person has submitted a notification within the time limits provided for by Article 14(2) of this Regulation, or where such a notification has been submitted and rejected pursuant to Article 17(4) or Article 17(5) thereof;where a notification has been submitted within the time limits provided for by Article 14(2) of this Regulation and has been found compliant pursuant to Article 17(5) thereof, but the substance identity in the notification only covers part of the existing identity in Annex II to this Regulation.In case referred to in point (c) of first paragraph, the draft non-approval decision shall cover any substance covered by the existing identity in Annex II to this Regulation, but not by the notification or any approval decision. Deleted by Commission Delegated Regulation (EU) 2017/698 of 3 February 2017 amending Delegated Regulation (EU) No 1062/2014 on the work programme for the systematic examination of all existing active substances contained in biocidal products referred to in Regulation (EU) No 528/2012 of the European Parliament and of the Council concerning the making available on the market and use of biocidal products (Text with EEA relevance).Substituted by Commission Delegated Regulation (EU) 2017/698 of 3 February 2017 amending Delegated Regulation (EU) No 1062/2014 on the work programme for the systematic examination of all existing active substances contained in biocidal products referred to in Regulation (EU) No 528/2012 of the European Parliament and of the Council concerning the making available on the market and use of biocidal products (Text with EEA relevance).Words in Art. 10(2) substituted (31.12.2020) by The Chemicals (Health and Safety) and Genetically Modified Organisms (Contained Use) (Amendment etc.) (EU Exit) Regulations 2019 (S.I. 2019/720), reg. 1(2), Sch. 2 para. 222(3)(a); 2020 c. 1, Sch. 5 para. 1(1)Words in Art. 10(2) omitted (31.12.2020) by virtue of The Chemicals (Health and Safety) and Genetically Modified Organisms (Contained Use) (Amendment etc.) (EU Exit) Regulations 2019 (S.I. 2019/720), reg. 1(2), Sch. 2 para. 222(3)(b); 2020 c. 1, Sch. 5 para. 1(1)Words in Art. 10(3) substituted (31.12.2020) by The Chemicals (Health and Safety) and Genetically Modified Organisms (Contained Use) (Amendment etc.) (EU Exit) Regulations 2019 (S.I. 2019/720), reg. 1(2), Sch. 2 para. 222(4); 2020 c. 1, Sch. 5 para. 1(1)Words in Art. 10(4) substituted (31.12.2020) by The Chemicals (Health and Safety) and Genetically Modified Organisms (Contained Use) (Amendment etc.) (EU Exit) Regulations 2019 (S.I. 2019/720), reg. 1(2), Sch. 2 para. 222(5); 2020 c. 1, Sch. 5 para. 1(1)Words in Art. 10 substituted (31.12.2020) by The Chemicals (Health and Safety) and Genetically Modified Organisms (Contained Use) (Amendment etc.) (EU Exit) Regulations 2019 (S.I. 2019/720), reg. 1(2), Sch. 2 para. 222(2); 2020 c. 1, Sch. 5 para. 1(1)Words in Art. 11(1)(a) omitted (31.12.2020) by virtue of The Chemicals (Health and Safety) and Genetically Modified Organisms (Contained Use) (Amendment etc.) (EU Exit) Regulations 2019 (S.I. 2019/720), reg. 1(2), Sch. 2 para. 223(2)(a)(i); 2020 c. 1, Sch. 5 para. 1(1)Words in Art. 11(1)(a) omitted (31.12.2020) by virtue of The Chemicals (Health and Safety) and Genetically Modified Organisms (Contained Use) (Amendment etc.) (EU Exit) Regulations 2019 (S.I. 2019/720), reg. 1(2), Sch. 2 para. 223(2)(a)(ii); 2020 c. 1, Sch. 5 para. 1(1)Words in Art. 11(1)(c) omitted (31.12.2020) by virtue of The Chemicals (Health and Safety) and Genetically Modified Organisms (Contained Use) (Amendment etc.) (EU Exit) Regulations 2019 (S.I. 2019/720), reg. 1(2), Sch. 2 para. 223(2)(b); 2020 c. 1, Sch. 5 para. 1(1)Words in Art. 11(1)(e) substituted (31.12.2020) by The Chemicals (Health and Safety) and Genetically Modified Organisms (Contained Use) (Amendment etc.) (EU Exit) Regulations 2019 (S.I. 2019/720), reg. 1(2), Sch. 2 para. 223(2)(c); 2020 c. 1, Sch. 5 para. 1(1)Word in Art. 11(2) omitted (31.12.2020) by virtue of The Chemicals (Health and Safety) and Genetically Modified Organisms (Contained Use) (Amendment etc.) (EU Exit) Regulations 2019 (S.I. 2019/720), reg. 1(2), Sch. 2 para. 223(3); 2020 c. 1, Sch. 5 para. 1(1)Art. 12(1) omitted (31.12.2020) by virtue of The Chemicals (Health and Safety) and Genetically Modified Organisms (Contained Use) (Amendment etc.) (EU Exit) Regulations 2019 (S.I. 2019/720), reg. 1(2), Sch. 2 para. 224(3); 2020 c. 1, Sch. 5 para. 1(1)Words in Art. 12(2) substituted (31.12.2020) by The Chemicals (Health and Safety) and Genetically Modified Organisms (Contained Use) (Amendment etc.) (EU Exit) Regulations 2019 (S.I. 2019/720), reg. 1(2), Sch. 2 para. 224(4); 2020 c. 1, Sch. 5 para. 1(1)Words in Art. 12(3) substituted (31.12.2020) by The Chemicals (Health and Safety) and Genetically Modified Organisms (Contained Use) (Amendment etc.) (EU Exit) Regulations 2019 (S.I. 2019/720), reg. 1(2), Sch. 2 para. 224(5)(a); 2020 c. 1, Sch. 5 para. 1(1)Words in Art. 12(3) omitted (31.12.2020) by virtue of The Chemicals (Health and Safety) and Genetically Modified Organisms (Contained Use) (Amendment etc.) (EU Exit) Regulations 2019 (S.I. 2019/720), reg. 1(2), Sch. 2 para. 224(5)(b); 2020 c. 1, Sch. 5 para. 1(1)Words in Art. 12 substituted (31.12.2020) by The Chemicals (Health and Safety) and Genetically Modified Organisms (Contained Use) (Amendment etc.) (EU Exit) Regulations 2019 (S.I. 2019/720), reg. 1(2), Sch. 2 para. 224(2); 2020 c. 1, Sch. 5 para. 1(1)Word in Art. 13(1) omitted (31.12.2020) by virtue of The Chemicals (Health and Safety) and Genetically Modified Organisms (Contained Use) (Amendment etc.) (EU Exit) Regulations 2019 (S.I. 2019/720), reg. 1(2), Sch. 2 para. 225(2)(a); 2020 c. 1, Sch. 5 para. 1(1)Words in Art. 13(1) omitted (31.12.2020) by virtue of The Chemicals (Health and Safety) and Genetically Modified Organisms (Contained Use) (Amendment etc.) (EU Exit) Regulations 2019 (S.I. 2019/720), reg. 1(2), Sch. 2 para. 225(2)(b); 2020 c. 1, Sch. 5 para. 1(1)Words in Art. 13(2) substituted (31.12.2020) by The Chemicals (Health and Safety) and Genetically Modified Organisms (Contained Use) (Amendment etc.) (EU Exit) Regulations 2019 (S.I. 2019/720), reg. 1(2), Sch. 2 para. 225(3)(a); 2020 c. 1, Sch. 5 para. 1(1)Words in Art. 13(2) substituted (31.12.2020) by The Chemicals (Health and Safety) and Genetically Modified Organisms (Contained Use) (Amendment etc.) (EU Exit) Regulations 2019 (S.I. 2019/720), reg. 1(2), Sch. 2 para. 225(3)(b); 2020 c. 1, Sch. 5 para. 1(1)Words in Art. 14(1) substituted (31.12.2020) by The Chemicals (Health and Safety) and Genetically Modified Organisms (Contained Use) (Amendment etc.) (EU Exit) Regulations 2019 (S.I. 2019/720), reg. 1(2), Sch. 2 para. 226; 2020 c. 1, Sch. 5 para. 1(1)Words in Art. 15 substituted (31.12.2020) by The Chemicals (Health and Safety) and Genetically Modified Organisms (Contained Use) (Amendment etc.) (EU Exit) Regulations 2019 (S.I. 2019/720), reg. 1(2), Sch. 2 para. 227(2); 2020 c. 1, Sch. 5 para. 1(1)Art. 15(aa) inserted (31.12.2020) by The Chemicals (Health and Safety) and Genetically Modified Organisms (Contained Use) (Amendment etc.) (EU Exit) Regulations 2019 (S.I. 2019/720), reg. 1(2), Sch. 2 para. 227(4) (as amended by S.I. 2020/1567, reg. 1(2), Sch. 2 para. 70); 2020 c. 1, Sch. 5 para. 1(1)Words in Art. 15(a) substituted (31.12.2020) by The Chemicals (Health and Safety) and Genetically Modified Organisms (Contained Use) (Amendment etc.) (EU Exit) Regulations 2019 (S.I. 2019/720), reg. 1(2), Sch. 2 para. 227(3)(a) (as amended by S.I. 2020/1567, reg. 1(2), Sch. 2 para. 70(a)); 2020 c. 1, Sch. 5 para. 1(1)Words in Art. 15(a) inserted (31.12.2020) by The Chemicals (Health and Safety) and Genetically Modified Organisms (Contained Use) (Amendment etc.) (EU Exit) Regulations 2019 (S.I. 2019/720), reg. 1(2), Sch. 2 para. 227(3)(b) (as amended by S.I. 2020/1567, reg. 1(2), Sch. 2 para. 70(a)); 2020 c. 1, Sch. 5 para. 1(1)Words in Art. 15(b) inserted (31.12.2020) by The Chemicals (Health and Safety) and Genetically Modified Organisms (Contained Use) (Amendment etc.) (EU Exit) Regulations 2019 (S.I. 2019/720), reg. 1(2), Sch. 2 para. 227(5); 2020 c. 1, Sch. 5 para. 1(1)Art. 15(c) omitted (31.12.2020) by virtue of The Chemicals (Health and Safety) and Genetically Modified Organisms (Contained Use) (Amendment etc.) (EU Exit) Regulations 2019 (S.I. 2019/720), reg. 1(2), Sch. 2 para. 227(6); 2020 c. 1, Sch. 5 para. 1(1)Art. 16(1) substituted (31.12.2020) by The Chemicals (Health and Safety) and Genetically Modified Organisms (Contained Use) (Amendment etc.) (EU Exit) Regulations 2019 (S.I. 2019/720), reg. 1(2), Sch. 2 para. 228(2); 2020 c. 1, Sch. 5 para. 1(1)Words in Art. 16(2) inserted (31.12.2020) by The Chemicals (Health and Safety) and Genetically Modified Organisms (Contained Use) (Amendment etc.) (EU Exit) Regulations 2019 (S.I. 2019/720), reg. 1(2), Sch. 2 para. 228(3); 2020 c. 1, Sch. 5 para. 1(1)Words in Art. 16(3) substituted (31.12.2020) by The Chemicals (Health and Safety) and Genetically Modified Organisms (Contained Use) (Amendment etc.) (EU Exit) Regulations 2019 (S.I. 2019/720), reg. 1(2), Sch. 2 para. 228(4)(a); 2020 c. 1, Sch. 5 para. 1(1)Words in Art. 16(3) substituted (31.12.2020) by The Chemicals (Health and Safety) and Genetically Modified Organisms (Contained Use) (Amendment etc.) (EU Exit) Regulations 2019 (S.I. 2019/720), reg. 1(2), Sch. 2 para. 228(4)(b); 2020 c. 1, Sch. 5 para. 1(1)Words in Art. 16(3) inserted (31.12.2020) by The Chemicals (Health and Safety) and Genetically Modified Organisms (Contained Use) (Amendment etc.) (EU Exit) Regulations 2019 (S.I. 2019/720), reg. 1(2), Sch. 2 para. 228(4)(c); 2020 c. 1, Sch. 5 para. 1(1)Words in Art. 16(3) substituted (31.12.2020) by The Chemicals (Health and Safety) and Genetically Modified Organisms (Contained Use) (Amendment etc.) (EU Exit) Regulations 2019 (S.I. 2019/720), reg. 1(2), Sch. 2 para. 228(4)(d); 2020 c. 1, Sch. 5 para. 1(1)Words in Art. 16(4) substituted (31.12.2020) by The Chemicals (Health and Safety) and Genetically Modified Organisms (Contained Use) (Amendment etc.) (EU Exit) Regulations 2019 (S.I. 2019/720), reg. 1(2), Sch. 2 para. 228(5); 2020 c. 1, Sch. 5 para. 1(1)Words in Art. 16(6) substituted (31.12.2020) by The Chemicals (Health and Safety) and Genetically Modified Organisms (Contained Use) (Amendment etc.) (EU Exit) Regulations 2019 (S.I. 2019/720), reg. 1(2), Sch. 2 para. 228(6)(a); 2020 c. 1, Sch. 5 para. 1(1)Words in Art. 16(6)(b) substituted (31.12.2020) by The Chemicals (Health and Safety) and Genetically Modified Organisms (Contained Use) (Amendment etc.) (EU Exit) Regulations 2019 (S.I. 2019/720), reg. 1(2), Sch. 2 para. 228(6)(b); 2020 c. 1, Sch. 5 para. 1(1)Art. 17(1) substituted (31.12.2020) by The Chemicals (Health and Safety) and Genetically Modified Organisms (Contained Use) (Amendment etc.) (EU Exit) Regulations 2019 (S.I. 2019/720), reg. 1(2), Sch. 2 para. 229(3); 2020 c. 1, Sch. 5 para. 1(1)Words in Art. 17(2) substituted (31.12.2020) by The Chemicals (Health and Safety) and Genetically Modified Organisms (Contained Use) (Amendment etc.) (EU Exit) Regulations 2019 (S.I. 2019/720), reg. 1(2), Sch. 2 para. 229(4); 2020 c. 1, Sch. 5 para. 1(1)Art. 17(3) omitted (31.12.2020) by virtue of The Chemicals (Health and Safety) and Genetically Modified Organisms (Contained Use) (Amendment etc.) (EU Exit) Regulations 2019 (S.I. 2019/720), reg. 1(2), Sch. 2 para. 229(5); 2020 c. 1, Sch. 5 para. 1(1)Art. 17(4) substituted (31.12.2020) by The Chemicals (Health and Safety) and Genetically Modified Organisms (Contained Use) (Amendment etc.) (EU Exit) Regulations 2019 (S.I. 2019/720), reg. 1(2), Sch. 2 para. 229(6); 2020 c. 1, Sch. 5 para. 1(1)Words in Art. 17(5) omitted (31.12.2020) by virtue of The Chemicals (Health and Safety) and Genetically Modified Organisms (Contained Use) (Amendment etc.) (EU Exit) Regulations 2019 (S.I. 2019/720), reg. 1(2), Sch. 2 para. 229(7); 2020 c. 1, Sch. 5 para. 1(1)Words in Art. 17(6) omitted (31.12.2020) by virtue of The Chemicals (Health and Safety) and Genetically Modified Organisms (Contained Use) (Amendment etc.) (EU Exit) Regulations 2019 (S.I. 2019/720), reg. 1(2), Sch. 2 para. 229(8); 2020 c. 1, Sch. 5 para. 1(1)Words in Art. 17(7)(a) substituted (31.12.2020) by The Chemicals (Health and Safety) and Genetically Modified Organisms (Contained Use) (Amendment etc.) (EU Exit) Regulations 2019 (S.I. 2019/720), reg. 1(2), Sch. 2 para. 229(9)(a); 2020 c. 1, Sch. 5 para. 1(1)Words in Art. 17(7)(b) substituted (31.12.2020) by The Chemicals (Health and Safety) and Genetically Modified Organisms (Contained Use) (Amendment etc.) (EU Exit) Regulations 2019 (S.I. 2019/720), reg. 1(2), Sch. 2 para. 229(9)(b); 2020 c. 1, Sch. 5 para. 1(1)Words in Art. 17 substituted (31.12.2020) by The Chemicals (Health and Safety) and Genetically Modified Organisms (Contained Use) (Amendment etc.) (EU Exit) Regulations 2019 (S.I. 2019/720), reg. 1(2), Sch. 2 para. 229(2); 2020 c. 1, Sch. 5 para. 1(1)Art. 18 substituted (31.12.2020) by The Chemicals (Health and Safety) and Genetically Modified Organisms (Contained Use) (Amendment etc.) (EU Exit) Regulations 2019 (S.I. 2019/720), reg. 1(2), Sch. 2 para. 230; 2020 c. 1, Sch. 5 para. 1(1)Words in Art. 19 omitted (31.12.2020) by virtue of The Chemicals (Health and Safety) and Genetically Modified Organisms (Contained Use) (Amendment etc.) (EU Exit) Regulations 2019 (S.I. 2019/720), reg. 1(2), Sch. 2 para. 231(b); 2020 c. 1, Sch. 5 para. 1(1)Words in Art. 19 substituted (31.12.2020) by The Chemicals (Health and Safety) and Genetically Modified Organisms (Contained Use) (Amendment etc.) (EU Exit) Regulations 2019 (S.I. 2019/720), reg. 1(2), Sch. 2 para. 231(a); 2020 c. 1, Sch. 5 para. 1(1)Word in Art. 20 heading omitted (31.12.2020) by virtue of The Chemicals (Health and Safety) and Genetically Modified Organisms (Contained Use) (Amendment etc.) (EU Exit) Regulations 2019 (S.I. 2019/720), reg. 1(2), Sch. 2 para. 232(2); 2020 c. 1, Sch. 5 para. 1(1)Words in Art. 20 substituted (31.12.2020) by The Chemicals (Health and Safety) and Genetically Modified Organisms (Contained Use) (Amendment etc.) (EU Exit) Regulations 2019 (S.I. 2019/720), reg. 1(2), Sch. 2 para. 232(3); 2020 c. 1, Sch. 5 para. 1(1)Words in Art. 20(a) substituted (31.12.2020) by The Chemicals (Health and Safety) and Genetically Modified Organisms (Contained Use) (Amendment etc.) (EU Exit) Regulations 2019 (S.I. 2019/720), reg. 1(2), Sch. 2 para. 232(4)(i); 2020 c. 1, Sch. 5 para. 1(1)Words in Art. 20(a) substituted (31.12.2020) by The Chemicals (Health and Safety) and Genetically Modified Organisms (Contained Use) (Amendment etc.) (EU Exit) Regulations 2019 (S.I. 2019/720), reg. 1(2), Sch. 2 para. 232(4)(ii); 2020 c. 1, Sch. 5 para. 1(1)Words in Art. 20 omitted (1.11.2022) by virtue of The Chemicals (Health and Safety) Trade and Miscellaneous Amendments Regulations 2022 (S.I. 2022/1037), regs. 1(2), 10(5)